Black Rock Coffee Bar opens two Arizona locations this week

TL;DR

Reports differ across sources; according to seekingalpha.com, topline Summary and Update I have viewed Black Diamond Therapeutics (BDTX) with substantial optimism over the past several articles, with the most recent entry back in November heralding a nearly 50% decline - Black Diamond Therapeutics (BDTX) remains a 'Buy', as silevertinib shows promising efficacy in EGFR-mutant NSCLC with notable CNS activity.